Log in

ASX:CD1US Select Private Opportunities Fund Stock Price, Forecast & News

A$0.74
+0.01 (+1.37 %)
(As of 05/12/2020)
Add
Today's Range
A$0.74
Now: A$0.74
A$0.74
50-Day Range
A$0.72
MA: A$1.17
A$1.63
52-Week Range
A$0.70
Now: A$0.74
A$2.25
Volume2,781 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
US Select Private Opportunities Fund, LP is a co-sponsored fund of Cordish Private Ventures LLC and Dixon Advisory and Superannuation Services Pty Ltd., Investment Arm. It specializes in fund of fund investments in buyout funds focused on small to lower middle-markets in the United States.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.28 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone1300 852 017

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CD1 News and Ratings via Email

Sign-up to receive the latest news and ratings for CD1 and its competitors with MarketBeat's FREE daily newsletter.

US Select Private Opportunities Fund (ASX:CD1) Frequently Asked Questions

How often does US Select Private Opportunities Fund pay dividends? What is the dividend yield for US Select Private Opportunities Fund?

US Select Private Opportunities Fund announced a Interim dividend on Monday, March 2nd. Stockholders of record on Thursday, March 19th will be paid a dividend of 0.40 per share on Thursday, March 19th. This represents a dividend yield of 25.32%. The ex-dividend date is Wednesday, March 4th. This is a positive change from US Select Private Opportunities Fund's previous Interim dividend of A$0.25. View US Select Private Opportunities Fund's dividend history.

Has US Select Private Opportunities Fund been receiving favorable news coverage?

News stories about CD1 stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. US Select Private Opportunities Fund earned a news impact score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutUS Select Private Opportunities Fund.

Who are US Select Private Opportunities Fund's key executives?

US Select Private Opportunities Fund's management team includes the following people:
  • Mr. Tristan Aloysius O'Connell BComm (ANU), CPA, F Fin, Fin. Director, Sec. & Director of Dixon Advisory & Superannuation Svcs Ltd
  • Mr. Christopher Matthew Brown, COO, MD & Director of Dixon Advisory & Superannuation Services Limited
  • Mr. Alan Cochrane Dixon BCom. (ANU), CA, Group MD & Director of Dixon Advisory & Superannuation Svcs Ltd
  • Mr. Alexander Gen MacLachlan B.A., M.B.A., BA, Ba (Cornell), MBA, Mba (Wharton), Managing Director
  • Ms. Hannah Chan, Sec. of Dixon Advisory & Superannuation Services Limited

What is US Select Private Opportunities Fund's stock symbol?

US Select Private Opportunities Fund trades on the ASX under the ticker symbol "CD1."

What is US Select Private Opportunities Fund's stock price today?

One share of CD1 stock can currently be purchased for approximately A$0.74.

What is US Select Private Opportunities Fund's official website?

The official website for US Select Private Opportunities Fund is www.cordishdixonfunds.com.au.

How can I contact US Select Private Opportunities Fund?

The company can be reached via phone at 1300 852 017.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.